- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Childhood Hodgkin Lymphoma in Finland
Total 166 results
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Childhood Hodgkin Lymphoma | Ann Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Ann Arbor Stage III Childhood Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Hodgkin LymphomaUnited States, Canada, Australia, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedStage III Childhood Hodgkin Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Stage I Childhood Hodgkin Lymphoma | Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma | Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma | Childhood Mixed Cellularity... and other conditionsUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland, Israel
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedStage III Childhood Hodgkin Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States, Canada, Israel, Australia, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant B-Cell LymphomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Israel
-
Turku University HospitalCompletedLymphoma | Lymphoma, Non-Hodgkin | Hodgkin DiseaseFinland
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Childhood Hodgkin LymphomaUnited States, Canada, Puerto Rico
-
Novartis PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaFinland, Spain, Korea, Republic of, Israel, Japan, Germany, Singapore
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingLymphoblastic Lymphoma, ChildhoodSpain, Austria, Denmark, Finland, Germany, Belgium, Switzerland, China, Czechia, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Imugene LimitedRecruitingNon-Hodgkin Lymphoma | B-cell Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)SuspendedRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin Lymphoma, Follicular LymphomaUnited Kingdom, Belgium, United States, Australia, Canada, Germany
-
University of NebraskaGlaxoSmithKline; Celgene CorporationCompletedNon-Hodgkin's LymphomaUnited States
-
Epizyme, Inc.RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular Lymphoma | Refractory Follicular LymphomaUnited States, China, Spain, France, Taiwan, United Kingdom, Australia, Korea, Republic of, Canada, Italy, Hungary, Poland, Belgium, Germany
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
Brown UniversityThe Miriam Hospital; Dartmouth-Hitchcock Medical Center; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedLymphoma, Non-HodgkinsUnited States
-
Artiva Biotherapeutics, Inc.RecruitingNon Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Lymphoblastic Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | B-cell Adult Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Vastra Gotaland RegionUnknownLymphoblastic Leukemia, Acute, ChildhoodFinland, Sweden
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Oslo University HospitalAarhus University Hospital; Hoffmann-La RocheRecruitingLymphoma, FollicularNorway, Finland
-
University of AarhusActive, not recruitingMalignant LymphomaNetherlands, Norway, Denmark, Finland, Sweden
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell LymphomaUnited States
-
Ascenta TherapeuticsCompletedFollicular LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic LymphomaUnited States, Puerto Rico
-
AmgenCompletedType II Refractory Celiac Disease (RCD-II) | In-situ Small Bowel T-cell LymphomaSpain, United States, Finland, France, Netherlands
-
Hoosier Cancer Research NetworkGenentech, Inc.; Millennium Pharmaceuticals, Inc.TerminatedLymphoma, Non-HodgkinUnited States
-
Brown UniversityTerminatedMantle Cell Lymphoma | Diffuse Large Cell Lymphoma | Burkitts Lymphoma | T Cell Lymphomas | Acute Myeloid Leukemia/Acute Lymphoblastic LeukemiaUnited States
-
Nordic Lymphoma GroupActive, not recruitingRelapsed Non Hodgkin LymphomaNorway, Sweden, Finland, Denmark
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Nordic Lymphoma GroupAmgenCompletedDiffuse Large B-Cell LymphomaNorway, Denmark, Finland, Sweden
-
Rigshospitalet, DenmarkNordic Society for Pediatric Hematology and OncologyCompletedAcute Lymphoblastic LeukemiaFinland, Denmark, Norway, Sweden, Iceland
-
NCIC Clinical Trials GroupCompleted
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); ShireActive, not recruitingAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States, Canada
-
Hoffmann-La RocheActive, not recruitingB-cell Non-Hodgkin LymphomaUnited States, Canada, Belgium, Spain, United Kingdom
-
Kymera Therapeutics, Inc.RecruitingSolid Tumors | T-cell Prolymphocytic Leukemia (T-PLL) | Non Hodgkin Lymphoma (NHL) | Peripheral T-cell Lymphoma (PTCL) | Cutaneous T-Cell Lymphoma (CTCL) | Large Granular Lymphocytic Leukemia (LGL-L)United States
-
University of AarhusNordic Lymphoma GroupCompletedPeripheral T-Cell LymphomaNorway, Finland, Denmark
-
Rigshospitalet, DenmarkNordic Society for Pediatric Hematology and OncologyCompletedAcute Lymphoblastic LeukemiaFinland, Denmark, Iceland, Norway, Sweden
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, France, Brazil, Ireland, Czechia, Romania, Argentina, Puerto Rico, Austria
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Genentech, Inc.; Oregon Health and Science University and other collaboratorsTerminatedCentral Nervous System B-Cell Non-Hodgkin LymphomaUnited States
-
University of AarhusCompletedRecurrence | Precursor Cell Lymphoblastic Leukemia-LymphomaFinland, Denmark, Iceland, Norway, Sweden
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Spectrum Pharmaceuticals, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Waldenstrom Macroglobulinemia | Lymphoma, Small-CellUnited States
-
Hoffmann-La RocheInstitute of Cancer Research, United Kingdom; German Low Grade Lymphoma Study...CompletedNon-Hodgkin's LymphomaItaly, Belgium, Canada, United Kingdom, Australia, China, Germany, United States, Russian Federation, Spain, Taiwan, Israel, Czechia, Hungary, Japan, France, Finland, Sweden